The effect of keratinocytes on the biomechanical characteristics and pore microstructure of tissue engineered skin using deep dermal fibroblasts

Biomaterials

Volumn 35, Issue 36, 2014, Pages 9591-9598

  Varkey, Mathew ^a   Ding, Jie ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Biomechanical characteristics; Keratinocytes; Pore microstructure; Tissue engineered skin

Indexed keywords

BIOMECHANICS; CELL CULTURE; FIBROBLASTS; MICROSTRUCTURE; PORE SIZE;

BIOCHEMICAL PATHWAY; BIOMECHANICAL CHARACTERISTICS; EXTRACELLULAR MATRICES; KERATINOCYTES; MATRIX CROSS-LINKING; PARENCHYMAL TISSUE; PORE MICROSTRUCTURES; TISSUE ARCHITECTURE;

TISSUE;

ARTICLE; BIOMECHANICS; CONTROLLED STUDY; CROSS LINKING; EPIDERMIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; TISSUE ENGINEERING; TISSUE STRUCTURE; ARTIFICIAL SKIN; CELL CULTURE; CHEMISTRY; COCULTURE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION; METABOLISM; POROSITY; PROCEDURES; TISSUE SCAFFOLD;

BIOMATERIAL;

BIOCOMPATIBLE MATERIALS; BIOMECHANICAL PHENOMENA; CELLS, CULTURED; COCULTURE TECHNIQUES; EPIDERMIS; FIBROBLASTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; POROSITY; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84922372497     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.048     Document Type: Article

References (30)

1. Amadeu T.P., Coulomb B., Desmouliere A., Costa A.M. Cutaneous wound healing: myofibroblastic differentiation and invitro models. Int J Low Extrem Wounds 2003, 2:60-68.
2. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. JClin Invest 2007, 117:524-529.
3. Scott P.G., Ghahary A., Tredget E.E. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 2000, 16:271-287.
4. Wynn T.A. Cellular and molecular mechanisms of fibrosis. JPathol 2008, 214:199-210.
5. Clark J.A., Cheng J.C., Leung K.S. Mechanical properties of normal skin and hypertrophic scars. Burns 1996, 22:443-446.
6. Rudolph R. Wide spread scars, hypertrophic scars, and keloids. Clin Plast Surg 1987, 14:253-260.
7. Bataller R., Brenner D.A. Liver fibrosis. JClin Invest 2005, 115:209-218.
8. Hold G.L., Untiveros P., Saunders K.A., El-Omar E.M. Role of host genetics in fibrosis. Fibrogenes Tissue Repair 2009, 2:6.
9. Bock O., Schmid-Ott G., Malewski P., Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006, 297:433-438.
10. Flemming R.G., Murphy C.J., Abrams G.A., Goodman S.L., Nealey P.F. Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 1999, 20:573-588.
11. Curtis A.S., Wilkinson C.D. Reactions of cells to topography. JBiomater Sci Polym Ed 1998, 9:1313-1329.
12. Yu H., Mouw J.K., Weaver V.M. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 2011, 21:47-56.
13. Erler J.T., Weaver V.M. Three-dimensional context regulation of metastasis. Clin Exp Metastasis 2009, 26:35-49.
14. Varkey M., Ding J., Tredget E.E. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials 2011, 32:7581-7591.
15. Takagi R., Yamato M., Murakami D., Kondo M., Yang J., Ohki T., et al. Preparation of keratinocyte culture medium for the clinical applications of regenerative medicine. JTissue Eng Regen Med 2011, 5:e63-73.
16. Varkey M., Ding J., Tredget E.E. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes. Tissue Eng Part A 2014, 20:716-727.
17. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
18. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. JCell Biol 1997, 136:729-743.
19. Nikolovska K., Renke J.K., Jungmann O., Grobe K., Iozzo R.V., Zamfir A.D., et al. Adecorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. Matrix Biol 2014, 35:91-102.
20. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999, 154:871-882.
21. Wang H.B., Dembo M., Wang Y.L. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. Am J Physiol Cell Physiol 2000, 279:C1345-C1350.
22. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
23. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. JCell Biol 2006, 172:259-268.
24. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. JCell Biol 2007, 179:1311-1323.
25. Georges P.C., Hui J.J., Gombos Z., McCormick M.E., Wang A.Y., Uemura M., et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1147-G1154.
26. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001, 70:1-32.
27. Kagan H.M., Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. JCell Biochem 2003, 88:660-672.
28. Murawaki Y., Kusakabe Y., Hirayama C. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin. Hepatology 1991, 14:1167-1173.
29. Sivakumar P., Gupta S., Sarkar S., Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol Cell Biochem 2008, 307:159-167.
30. Mosher D.F., Schad P.E. Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa. JClin Invest 1979, 64:781-787.